Contact
Please use this form to send email to PR contact of this press release:
Retrotope Announces First Dosing of RT001 in patients with Infantile Neuroaxonal Dystrophy (INAD)
TO:
Please use this form to send email to PR contact of this press release:
Retrotope Announces First Dosing of RT001 in patients with Infantile Neuroaxonal Dystrophy (INAD)
TO: